CoreCap Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Buy
2,945
+650
+28% +$52.4K 0.01% 813
2026
Q1
$199K Sell
2,295
-3,553
-61% -$340K 0.01% 805
2025
Q4
$562K Buy
5,848
+1,740
+42% +$169K 0.02% 490
2025
Q3
$391K Buy
4,108
+1,583
+63% +$146K 0.01% 584
2025
Q2
$220K Sell
2,525
-249
-9% -$21.1K 0.01% 715
2025
Q1
$249K Buy
2,774
+530
+24% +$47.4K 0.01% 627
2024
Q4
$179K Buy
2,244
+322
+17% +$27.9K 0.01% 734
2024
Q3
$173K Sell
1,922
-23,710
-93% -$1.99M 0.01% 735
2024
Q2
$2.02M Buy
25,632
+1,031
+4% +$84.5K 0.21% 103
2024
Q1
$2.14M Buy
+24,601
New +$2.1M 0.11% 180
2022
Q4
$114K Buy
+1,465
New +$119K 0.01% 691
2022
Q3
Sell
-1,503
Closed -$135K 1445
2022
Q2
$135K Sell
1,503
-920
-38% -$93.2K 0.01% 601
2022
Q1
$269K Sell
2,423
-4,249
-64% -$449K 0.02% 434
2021
Q4
$690K Buy
+6,672
New +$773K 0.05% 302

Other funds holding MDT

CoreCap Advisors's MDT Position: Q2 2026 in Review

CoreCap Advisors increased its Medtronic (MDT) stake by 28% in Q2 2026, buying an estimated $52.4K and bringing the position to 2,945 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #813.

CoreCap Advisors first reported a position in MDT in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.14M in Q1 2024. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CoreCap Advisors held 2,945 shares of Medtronic worth $230K as of Q2 2026.
  • CoreCap Advisors bought 650 Medtronic shares in Q2 2026, an estimated $52.4K.
  • Medtronic made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #813 holding.
  • CoreCap Advisors first reported a position in Medtronic in Q4 2021 and has held it in 14 quarters since.
  • CoreCap Advisors's Medtronic position peaked at $2.14M in Q1 2024.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.